Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,017 | 213 | 97.1% |
| Education | $90.92 | 6 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $870.46 | 60 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $478.23 | 29 | $0 (2020) |
| GlaxoSmithKline, LLC. | $246.06 | 20 | $0 (2020) |
| Astellas Pharma US Inc | $209.97 | 12 | $0 (2019) |
| Lilly USA, LLC | $207.19 | 20 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $182.61 | 17 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $127.00 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $121.71 | 10 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.52 | 6 | $0 (2017) |
| Novo Nordisk Inc | $101.98 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $0.79 | 1 | Sumitomo Pharma America, Inc. ($0.79) |
| 2021 | $55.46 | 3 | AbbVie Inc. ($21.90) |
| 2020 | $200.34 | 13 | Amgen Inc. ($80.02) |
| 2019 | $937.99 | 62 | Amgen Inc. ($351.55) |
| 2018 | $856.10 | 60 | Amgen Inc. ($223.49) |
| 2017 | $1,057 | 80 | Amgen Inc. ($201.08) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/11/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 03/24/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Bone Health | ||||||
| 02/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 01/20/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Neuroscience | ||||||
| 08/31/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Neuroscience | ||||||
| 03/03/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: RESPIRATORY | ||||||
| 03/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Neuroscience | ||||||
| 02/12/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular | ||||||
| 01/27/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Neuroscience | ||||||
| 01/23/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/15/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/13/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Bone Health | ||||||
| 01/07/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Cardiovascular | ||||||
| 12/16/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: UROLOGY | ||||||
| 12/04/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Neuroscience | ||||||
| 11/25/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Neuroscience | ||||||
| 11/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Bone Health | ||||||
| 11/06/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/04/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,108 | 3,642 | $389,798 | $119,731 |
| 2022 | 24 | 2,391 | 3,940 | $439,854 | $134,472 |
| 2021 | 25 | 2,381 | 3,852 | $406,235 | $128,345 |
| 2020 | 29 | 2,747 | 4,065 | $391,159 | $114,284 |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 710 | $163,300 | $59,207 | 36.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 204 | 204 | $56,100 | $25,800 | 46.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 75 | 78 | $6,165 | $5,812 | 94.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 235 | 479 | $59,875 | $4,944 | 8.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 244 | 586 | $8,790 | $4,893 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 77 | $12,320 | $4,845 | 39.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 226 | 330 | $19,800 | $2,506 | 12.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 153 | 182 | $12,558 | $2,388 | 19.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 77 | $3,850 | $2,272 | 59.0% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 152 | 210 | $7,350 | $1,340 | 18.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 212 | 271 | $8,130 | $1,065 | 13.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 27 | 27 | $9,450 | $989.96 | 10.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 15 | $2,250 | $746.70 | 33.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 34 | 42 | $3,990 | $691.32 | 17.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 35 | 35 | $3,325 | $662.20 | 19.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 32 | 37 | $3,515 | $655.03 | 18.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 63 | $3,150 | $517.94 | 16.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 25 | $2,000 | $258.44 | 12.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 194 | $3,880 | $137.71 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 257 | 789 | $181,470 | $67,781 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 217 | 217 | $59,675 | $27,833 | 46.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 90 | 91 | $7,735 | $6,377 | 82.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 96 | $15,360 | $5,589 | 36.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 245 | 469 | $58,625 | $4,874 | 8.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 242 | 350 | $21,000 | $2,685 | 12.8% |
About Dr. Philip Maple, M.D
Dr. Philip Maple, M.D is a Internal Medicine healthcare provider based in Fredericksburg, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386688810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Maple, M.D has received a total of $3,108 in payments from pharmaceutical and medical device companies, with $0.79 received in 2023. These payments were reported across 219 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,017).
As a Medicare-enrolled provider, Maple has provided services to 9,627 Medicare beneficiaries, totaling 15,499 services with total Medicare billing of $496,831. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fredericksburg, TX
- Active Since 06/15/2006
- Last Updated 04/04/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386688810
Products in Payments
- Prolia (Biological) $362.83
- XARELTO (Drug) $298.32
- EVENITY (Biological) $204.59
- Aimovig (Biological) $177.52
- INVOKANA (Drug) $167.33
- JARDIANCE (Drug) $127.04
- MYRBETRIQ (Drug) $125.94
- Repatha (Biological) $111.52
- TRELEGY ELLIPTA (Drug) $98.40
- TOUJEO (Drug) $90.83
- TRULICITY (Drug) $90.38
- XIFAXAN (Drug) $89.93
- JANUVIA (Drug) $87.48
- Victoza (Drug) $82.74
- SYMBICORT (Drug) $81.42
- FORTEO (Drug) $78.82
- Trintellix (Drug) $70.43
- BREO (Drug) $50.53
- Vascepa (Drug) $48.09
- ANORO (Drug) $46.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fredericksburg
Matthew Whitehurst, Md, MD
Internal Medicine — Payments: $34,621
Kenneth Mcdowell, Do, DO
Internal Medicine — Payments: $17,181
Dr. Norman Chang, M.d, M.D
Internal Medicine — Payments: $11,733
Dr. Veena Vangani, Md, MD
Internal Medicine — Payments: $11,338
Dr. Ethan Ko, Do, DO
Internal Medicine — Payments: $10,053
Dr. Bozena Wolanska, M.d, M.D
Internal Medicine — Payments: $9,531